{
    "code": "01056647",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01056647",
    "time": "2022-05-13 03:14:15",
    "許可證字號": "衛署藥製字第056647號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/07\/21",
    "發證\/登錄日期": "100\/07\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00105664708",
    "中文品名": "紓心膠囊",
    "英文品名": "Sotrel Capsules",
    "適應症": "治療高血壓，此複方藥品不適合用於起始治療",
    "劑型": "130膠囊劑",
    "包裝": "2~1000粒塑膠瓶裝 2~1000粒PVC-PVDC\/ALU-FOIL鋁箔盒裝 2~1000粒ALU-ALU\/ALU-FOIL鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE",
    "限制項目": "01國　產 09委託製造 61完成BE試驗",
    "申請商名稱": "620101P998  東生華製藥股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓之1",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2412402210",
            "成分名稱": "AMLODIPINE BESYLATE",
            "含量描述": "",
            "含量": "7.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2408004510",
            "成分名稱": "BENAZEPRIL HYDROCHLORIDE",
            "含量描述": "",
            "含量": "10.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "P-紓心膠囊-1050331-仿單賦形劑已送件變更為學名-105-03-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056647&Seq=004&Type=9"
        },
        {
            "title": "紓心膠囊-鋁箔-104-12-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01056647&Seq=009&Type=8"
        }
    ]
}